Episode

📣 Digital Health Download: March 2026

Podcast
The Heart of Healthcare | A Digital Health Podcast
Published
Mar 2, 2026
Duration seconds
1866
Processing state
not_requested
Canonical source
https://rss.art19.com/episodes/691dddda-8f07-49ad-9def-45e7e9a62dbd.mp3?rss_browser=BAhJIg90cmFuc2NyaWJyBjoGRVQ%3D--952c5701c84ad333c69d5faa668f8177091704f0
Audio
https://rss.art19.com/episodes/691dddda-8f07-49ad-9def-45e7e9a62dbd.mp3?rss_browser=BAhJIg90cmFuc2NyaWJyBjoGRVQ%3D--952c5701c84ad333c69d5faa668f8177091704f0
JSON
/v1/public/podcasts/the-heart-of-healthcare-a-digital-health-podcast-4062107/episodes/digital-health-download-march-2026
Markdown
/podcast/the-heart-of-healthcare-a-digital-health-podcast-4062107/digital-health-download-march-2026.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-heart-of-healthcare-a-digital-health-podcast-4062107/episodes/digital-health-download-march-2026/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-heart-of-healthcare-a-digital-health-podcast-4062107/digital-health-download-march-2026.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Pharma ads, biotech IPOs, $1M longevity programs, oh my! This month's Digital Health Download skews towards biotech, which is having a moment. Tune in to hear Halle and Michael cover the latest headlines. We cover: Why pharma ads are surging and the growing push for restrictions on D2C drug advertising Hims & Hers’ $1.15B acquisition of Eucalyptus, its global expansion strategy, and the FDA crackdown on compounded GLP‑1 drugs The return of biotech IPOs, with Eikon Therapeutics and Generate Biomedicines signaling investor interest in platform‑based drug discovery Vaccine makers scaling back research amid policy uncertainty, declining uptake, and tighter funding TrumpRx’s “most favored nation” drug pricing approach, and what one STAT analysis found Bryan Johnson’s $1M per year “Immortals” longevity program — Show notes: Should drug companies be advertising to consumers? (The New York Times)  Hims & Hers Enters $1.15 Billion Agreement to Acquire Eucalyptus (PharmExec.com) A sign biotech is back? Four drugmakers go public, raising nearly $1 billion in all (STAT) Vaccine Makers Curtail Research and Cut Jobs (The New York Times)  TrumpRx claims to offer the lowest prices. But many drugs have cheaper generics (STAT) Bryan Johnson's Immortals: $1M to try longevity regimen (Axios)  — "Halle Tecco wanted to see tech used for better medical services and getting people engaged in their own health. Now, she’s written a book on how she went about it." - The WSJ Massively Better Healthcare is out now! — Rock Health's annual CEO Summit is returning to the New York Stock Exchange on March 27th! Learn more and nominate a CEO to join this invite-only event here . — 📍 Connect with us: Heart of Healthcare website LinkedIn Instagram Youtube See Privacy Policy at…